Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Amarin Corporation plc
AMRN | US
14.31
USD-0.28
-1.92%
AMRN | US
Loading StockChartView...
About Amarin Corporation plc
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
24/04/2026
Close
14.31
Open
14.56
High
14.88
Low
14.00
Amarin Corporation plc a pharmaceutical company engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States European countries Canada Lebanon and the United Arab Emirates. It offers VASCEPA a prescription-only omega-3 fatty acid product used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. The company sells its products principally to wholesalers and specialty pharmacy providers. It has a collaboration with Mochida Pharmaceutical Co. Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin Ireland.
View LessAMRN | US
Risk
31.0
Sharpe
0.61
Luna's Score
43/100
Recommendation
Sell
Luna says (AMRN | US)
What's Working
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
What's not Working
Negative Momentum (Declining Price)
Weakness based on declining price with high volume
Price Below SMA10D
Midcap (2B - 10B USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
Loading RiskMeterView...
10 days
34.4%1 month
31.0%3 months
45.2%6 months
52.5%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
500.00
Price to book
0.42
Debt to equity
0.01
Debt to assets
0.01
Ent. to EBITDA
-5.80
Ent. to rev.
0.08
PEG
-1.74
Other Fundamentals
EBITDA
-23.79M
MarketCap
5.88B
MarketCap(USD)
5.88B
Div. yield
-
Op. margin
-0.78
Erngs. growth
-94.20
Rev. growth
-15.80
Ret. on equity
-5.98
Short ratio
26.50
Short perc.
4.40
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
1.21
Range1M
1.45
Range3M
3.80
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
1.49
Price X volume
1.04M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -5.80 | 0.53 | Cheaper |
| Ent. to Revenue | 0.08 | 3,967.00 | Cheaper |
| PE Ratio | - | 41.03 | - |
| Price to Book | 0.42 | 15.55 | Cheaper |
| Dividend Yield | - | 2.20 | - |
| Std. Deviation (3M) | 45.23 | 72.80 | Lower Risk |
| Debt to Equity | 0.01 | -1.23 | Expensive |
| Debt to Assets | 0.01 | 0.25 | Cheaper |
| Market Cap | 5.88B | 3.66B | Market Leader |
